ReqMed Company appeared to be the Corporate Investor, which was created in 1998.
The typical case for the fund is to invest in rounds with 8 participants. Despite the ReqMed Company, startups are often financed by Lombard Odier. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Lombard Odier, Hambrecht & Quist Capital Management. In the next rounds fund is usually obtained by Tekla Capital Management, Silicon Valley Bank, OrbiMed.
Among the various public portfolio startups of the fund, we may underline Agensys Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical.
The higher amount of exits for fund were in 2007. The high activity for fund was in 2002. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| BlackDragon | City of Zagreb, Croatia, Zagreb |
| Blueprint Ventures | California, San Francisco, United States |
| BMC Ventures | Montreux, Switzerland, Vaud |
| CLP Data Services | - |
| Daoji Investment | China, Shanghai |
| Eterna Capital | England, London, United Kingdom |
| Fidelity Biosciences | - |
| Gemini Funds | Hauppauge, New York, United States |
| Huirun Dongfang Touzi Jijin | Beijing, China, Fengtai |
| IFC InfraVentures | District of Columbia, United States, Washington |
| Mathers Associates | - |
| Maven 11 Capital | Amsterdam, Noord-Holland, The Netherlands |
| Radest Ventures | - |
| Ruipeng Touzi | China, Shaanxi, Yanliang |
| SDIC Fund Management | Beijing, Beijing, China |
| Security Bank Corporation | Makati, Manila, Philippines |
| SVG Ventures | California, Los Gatos, United States |
| Swift Ventures | - |
| Zhongguo Qiye Lianhe Hui | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Agensys | $42M | 04 Mar 2002 | Santa Monica, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Agensys | $42M | 04 Mar 2002 | Santa Monica, California, United States |
